Splanchnic nerve stimulation for treatment of obesity

• US 20040230255A1
• Filed: 02/24/2004
• Published: 11/18/2004
• Est. Priority Date: 03/22/2002
• Status: Active Grant

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Leptos Biomedical, Inc. (Abbott Laboratories Incorporated)
• Inventors: Dobak, John D. III
• Granted Patent: US 7,551,964 B2
• Time in Patent Office: Days
• US Class Current: 607/58
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity

Abstract

A method for the treatment of obesity or other disorders by electrical activation or inhibition of the sympathetic nervous system is disclosed. This activation or inhibition can be accomplished by stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an electrode. This nerve activation can result in reduced food intake and increased energy expenditure.

Claims

1. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern configured to result in net weight loss in the mammal;

wherein the stimulation pattern comprises a stimulation intensity, an on time, and an off time; and

wherein the stimulation pattern is configured such that the ratio of the on time to the off time is about 0.75 or less.

2. The method of claim 1, wherein the stimulation pattern is configured such that the ratio of the on time to the off time is about 0.5 or less.

3. The method of claim 2, wherein the stimulation pattern is configured such that the ratio of the on time to the off time is about 0.3 or less.

4. The method of claim 1, wherein the stimulation pattern is configured such that the on time is about two minutes or less.

5. The method of claim 4, wherein the stimulation pattern is configured such that the on time is about one minute or less.

6. The method of claim 5, wherein the stimulation pattern is configured such that the on time is about one minute or less and the off time is about one minute or more.

7. The method of claim 1, wherein the stimulation pattern is configured such that the on time is greater than about 15 seconds.

8. The method of claim 7, wherein the stimulation pattern is configured such that the on time is greater than about 30 seconds.

9. The method of claim 1, further comprising varying the stimulation intensity over time.

10. The method of claim 9, further comprising increasing the stimulation intensity over time.

11. The method of claim 10, further comprising increasing the stimulation intensity daily.

12. The method of claim 10, further comprising creating a unidirectional action potential in the splanchnic nerve.

13. The method of claim 10, further comprising creating an anodal block in the splanchnic nerve.

14. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern for a first time period;

wherein the stimulation pattern comprises a stimulation intensity and is configured to result in net weight loss in the mammal during the first time period; and

reducing or ceasing the electrical activation of the splanchnic nerve for a second time period, such that the mammal loses net weight during the second time period.

15. The method of claim 14, wherein the first time period is between about 2 weeks and about 15 weeks.

16. The method of claim 15, wherein the first time period is between about 6 weeks and about 12 weeks.

17. The method of claim 14, wherein the second time period is between about 1 week and about 6 weeks.

18. The method of claim 17, wherein the second time period is between about 2 weeks and about 4 weeks.

19. The method of claim 14, further comprising varying the stimulation intensity during the first time period.

20. The method of claim 19, further comprising increasing the stimulation intensity during the first time period.

21. The method of claim 20, further comprising increasing the stimulation intensity daily during the first time period.

22. The method of claim 14, wherein the electrically activating the splanchnic nerve comprises delivering a stimulation intensity to the splanchnic nerve that is approximately equal to the stimulation intensity required to produce skeletal muscle twitching in the mammal.

23. The method of claim 14, wherein the electrically activating the splanchnic nerve comprises delivering a stimulation intensity to the splanchnic nerve that is at least about two times the stimulation intensity required to produce skeletal muscle twitching in the mammal.

24. The method of claim 23, wherein the electrically activating the splanchnic nerve comprises delivering a stimulation intensity to the splanchnic nerve that is at least about five times the stimulation intensity required to produce skeletal muscle twitching in the mammal.

25. The method of claim 24, wherein the electrically activating the splanchnic nerve comprises delivering a stimulation intensity to the splanchnic nerve that is at least about eight times the stimulation intensity required to produce skeletal muscle twitching in the mammal.

26. The method of claim 14, further comprising creating a unidirectional action potential in the splanchnic nerve.

27. The method of claim 14, further comprising creating an anodal block in the splanchnic nerve.

28. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern for a first time period within a period of about 24 hours, said stimulation pattern comprising a stimulation intensity and being configured to result in net weight loss in the mammal; and

ceasing the electrical activation of the a splanchnic nerve for a second time period within the period of about 24 hours.

29. The method of claim 28, further comprising repeating the steps of electrically activating and ceasing the electrical activation.

30. The method of claim 28, wherein the first time period plus the second time period equals about 24 hours.

31. The method of claim 28, further comprising varying the stimulation intensity over time.

32. The method of claim 31, further comprising increasing the stimulation intensity over time.

33. The method of claim 32, further comprising increasing the stimulation intensity daily.

34. The method of claim 28, further comprising creating a unidirectional action potential in the splanchnic nerve.

35. The method of claim 28, further comprising creating an anodal block in the splanchnic nerve.

36. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern configured to result in net weight loss in the mammal;

wherein the stimulation pattern comprises a stimulation intensity and a frequency; and

wherein the frequency is about 15 Hz or greater, to minimize skeletal muscle twitching.

37. The method of claim 36, wherein the frequency is about 20 Hz or greater.

38. The method of claim 37, wherein the frequency is about 30 Hz or greater.

39. The method of claim 36, wherein the stimulation intensity is at least about 5 times the stimulation intensity required to produce skeletal muscle twitching in the mammal.

40. The method of claim 39, wherein the stimulation intensity is at least about 10 times the stimulation intensity required to produce skeletal muscle twitching in the mammal, and the frequency is about 20 Hz or greater.

41. The method of claim 36, further comprising creating a unidirectional action potential in the splanchnic nerve.

42. The method of claim 36, further comprising creating an anodal block in the splanchnic nerve.

43. A method for producing weight loss, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern comprising a stimulation intensity and a frequency; and

the stimulation pattern is configured to decrease absorption of food from the gastrointestinal tract, resulting in increased stool output in the mammal.

44. The method of claim 43, wherein the frequency is about 15 Hz or greater.

45. The method of claim 44, wherein the frequency is about 20 Hz or greater.

46. The method of claim 45, wherein the frequency is about 30 Hz or greater.

47. The method of claim 43, wherein the stimulation intensity is at least about 5 times the stimulation intensity required to produce skeletal muscle twitching in the mammal.

48. The method of claim 47, wherein the stimulation intensity is at least about 10 times the stimulation intensity required to produce skeletal muscle twitching in the mammal, and the frequency is about 20 Hz or greater.

49. A method for treating a medical condition, the method comprising:

placing an electrode in proximity to a splanchnic nerve in a mammal above the diaphragm; and

electrically activating the splanchnic nerve.

50. The method of claim 49, further comprising placing the electrode in contact with the splanchnic nerve.

51. The method of claim 49, wherein the electrode is helical or has a cuff, and further comprising attaching the electrode to the splanchnic nerve.

52. The method of claim 49, wherein the placing is transcutaneous.

53. The method of claim 49, wherein the placing is into a blood vessel of the mammal.

54. The method of claim 53, wherein the blood vessel is an azygous vein.

55. The method of claim 49, further comprising creating a unidirectional action potential in the splanchnic nerve.

56. The method of claim 49, further comprising creating an anodal block in the splanchnic nerve.

57. The method of claim 49, further comprising electrically activating the electrode and observing the patient for skeletal muscle twitching to assess placement of the electrode near the splanchnic nerve.

59. The method of claim 54, wherein the blood vessel is an azygous vein.

60. The method of claim 54, wherein the electrically activating is according to a stimulation pattern configured to result in net weight loss in the mammal.

58. A method for treating a medical condition, the method comprising:

placing an electrode into a blood vessel of a mammal, in proximity to a splanchnic nerve of the mammal; and

electrically activating the splanchnic nerve via the electrode.

61. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern configured to result in net weight loss in the mammal;

wherein the stimulation pattern comprises an on time; and

wherein the on time is adjusted based on a blood pressure of the mammal.

62. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern configured to result in net weight loss in the mammal;

wherein the stimulation pattern comprises an on time; and

wherein the on time is adjusted based on a plasma PYY concentration in the mammal.

63. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern configured to result in net weight loss in the mammal;

wherein the stimulation pattern comprises an on time; and

wherein the on time is adjusted based on a plasma ghrelin concentration in the mammal.

64. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern, wherein the stimulation pattern comprises a current amplitude;

wherein the current amplitude is adjusted based on skeletal muscle twitching in the mammal.

65. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern, wherein the stimulation pattern comprises a current amplitude and a pulse width;

wherein the current amplitude is increased to a first level at which skeletal muscle twitching begins to occur in the mammal;

keeping the current amplitude at or near the first level until the skeletal muscle twitching decreases or ceases.

66. The method of claim 65, further comprising further increasing the current amplitude as habituation to the skeletal muscle twitching occurs.

67. The method of claim 65, further comprising further increasing the current amplitude to a second level at which skeletal muscle twitching begins to recur, the second level being greater than the first level.

68. The method of claim 65, further comprising creating a unidirectional action potential in the splanchnic nerve.

69. The method of claim 65, further comprising creating an anodal block in the splanchnic nerve.

70. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern, wherein the stimulation pattern comprises a current amplitude and a pulse width;

wherein the current amplitude is increased to a first level at which skeletal muscle twitching begins to occur in the mammal;

increasing the pulse width while keeping the current amplitude at about the first level or below the first level.

71. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern, wherein the stimulation pattern comprises a current amplitude;

wherein the current amplitude is increased to a first level at which skeletal muscle twitching begins to occur in the mammal; and

sensing the muscle twitching with a sensor in electrical communication with the electrode.

72. The method of claim 71, wherein the sensor is electrical.

73. The method of claim 71, wherein the sensor is mechanical.

74. The method of claim 71, further comprising implanting the sensor near the abdominal wall to sense abdominal muscle twitching.

75. The method of claim 71, further comprising creating a unidirectional action potential in the splanchnic nerve.

76. The method of claim 71, further comprising creating an anodal block in the splanchnic nerve.

77. A device for treating a medical condition, the device comprising:

an electrode configured to stimulate electrically a splanchnic nerve in a mammal;

a generator configured to deliver an electrical signal to the electrode; and

a sensor in electrical communication with the generator, the sensor configured to sense muscle twitching;

wherein the device is programmed to stimulate electrically the splanchnic nerve according to a stimulation pattern, wherein the stimulation pattern comprises a current amplitude and a pulse width;

wherein the device is further programmed to increase the current amplitude to a first level at which skeletal muscle twitching begins to occur, and temporarily hold the current amplitude at or near the first level until the skeletal muscle twitching decreases or ceases.

78. The device of claim 77, wherein the device is further programmed to increase the pulse width while keeping the current amplitude at or near the first level.

79. The device of claim 77, wherein the device is further programmed to increase the current amplitude as habituation to the muscle twitching occurs.

80. The device of claim 77, wherein the device is further programmed to increase the current amplitude to a second level at which skeletal muscle twitching begins to recur, the second level being greater than the first level.

81. The device of claim 77, wherein the device is compatible with magnetic resonance imaging.

82. The device of claim 81, wherein the device comprises a nanomagnetic material.

83. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern that is configured to result in net weight loss in the mammal while avoiding a substantial rise in a blood pressure of the mammal.

84. A method for treating a medical condition, the method comprising:

electrically activating a splanchnic nerve in a mammal according to a stimulation pattern that is configured to result in net weight loss in the mammal while avoiding prolonged skeletal muscle twitching in the mammal.